Hepatocellular Carcinoma — Trials

Hepatocellular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 693
Recruiting: 411
Ph III recruiting: 39
Growth YoY: +0.6%
Industry share: 23%
Top sponsor: Sun Yat-sen University
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (357)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07298577	Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer(STOPHCC-GAAD)	enrolling by invitation	N/A	2,100	Siriraj HospitalOTHER	1	Apr 24, 2026	clinicaltrials
NCT06061328	Project OASIS: Optimizing Approaches to Select Implementation Strategies(OASIS)	enrolling by invitation	N/A	8,020	VA Office of Research and Development